MedPlus Health Services subsidiary, Optival Health Solutions Private Limited, has received a temporary suspension order for a Drug License at one of its Karnataka stores. The suspension is effective for one day, stemming from an order dated February 19, 2026. The potential financial impact due to this brief closure is estimated to be a revenue loss of approximately Rs 0.33 lakh. The company confirms this operational update has been disclosed to the stock exchanges.
Operational Update on Subsidiary Compliance
MedPlus Health Services Limited wishes to update stakeholders regarding its subsidiary, Optival Health Solutions Private Limited. The subsidiary has been issued a suspension order concerning the Drug License of a retail store located in Karnataka.
Details of Regulatory Action
The authority that issued the order was the Assistant Director, Drugs Control Administration, Tumkur Circle, Tumkur, Karnataka. The core action taken was the Suspension of the Drug License for the store situated in Koratagere, Tumkur, Karnataka.
- Duration: The suspension is for one day.
- Date of Order Receipt: 19.02.2026.
- Governing Rule: The action was taken under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945.
Financial Impact Assessment
The company has quantified the direct financial impact resulting from this temporary closure. The potential revenue loss due to the one-day suspension is calculated to be Rs 0.33 lakh. The matter does not involve any ongoing litigation or contravention that is quantifiable in monetary terms beyond this immediate loss.
Public Disclosure
This information, mandated for public disclosure, will be made available on the official websites of MedPlus Health Services Limited, the BSE Limited, and the National Stock Exchange of India Ltd.
Source: BSE
